The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.

Higher lactate concentrations and hypotension are independently linked to increased mortality risk in critically ill adults with COVID-19.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates.

The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.

Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

“The iREACH intervention was effective in improving pediatric clinician adherence to the 2017 PPA guidelines for infants at high and low risk of PA,” the study authors concluded. “Wide dissemination ...

For decades, the CDC has released a yearly report tracking national abortion trends, but this year’s report has been delayed until spring.

Heart failure associated with sarcoidosis has higher mortality risk than HF associated with ischemic heart disease or dilated cardiomyopathy.